For people with alcohol use disorder (AUD), there is a constant, vicious cycle between changes to the brain and changes to behavior. AUD can alter signaling pathways in the brain; in turn, those changes can exacerbate drinking.
Mar 6, 2023
1
1026
The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study publishing March 2nd in the open access journal PLoS Biology ...
Mar 2, 2023
0
53
Scientists at Open Targets, EMBL's European Bioinformatics Institute (EMBL-EBI), and GSK are revealing the shared basis of diseases using a map of interacting human proteins. By helping to understand how biological processes ...
Feb 23, 2023
0
47
Scientists at Scripps Research, with collaborators in Japan, have discovered how a "poisoned" form of a protein could set off a cascade of events that encourage the growth of some cancers. The research, published in Nature ...
Feb 16, 2023
0
20
High drug prices are not justified by industry's spending on research and development (R&D), argue experts in The BMJ today.
Feb 15, 2023
1
80
Artificial intelligence that could reduce the cost and speed-up the discovery of new medicines has been developed as part of a collaboration between researchers at the University of Sheffield and AstraZeneca.
Feb 3, 2023
1
137
As a child, Lynn Aureli didn't know that a particular genetic change contributed to her acute myeloid leukemia (AML)—an alteration that eventually would help explain the cancer's lack of response to chemotherapy. Nor was ...
Jan 27, 2023
0
26
People who are overweight or obese have a significantly increased risk of developing diabetes, but exactly how that happens is not well understood.
Jan 11, 2023
0
23
Researchers at the University of Tokyo have used artificial DNA to target and kill cancer cells in a completely new way. The method was effective in lab tests against human cervical cancer- and breast cancer-derived cells, ...
Dec 21, 2022
0
78
A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone anabolic therapies using a selected aptamer that serves as an inhibitor of sclerostin, a protein that prevents bone growth. ...
Dec 19, 2022
0
69
